The study of Pharmacodynamics focuses on how medications affect the body. The drug's interaction with tissue receptors found within cell membranes or intracellular fluid is the most frequent method. The amount of the activating medication (the "agonist") affects the degree of receptor activation and the ensuing biological reaction. The dose-response curve, which charts the medication dose (or concentration) against its effect, provides an explanation for this relationship. Patient characteristics (such as age and illness) and the availability of additional medications that compete with it for binding at the same receptor (such as receptor "antagonists") might have an impact on this crucial pharmacodynamic interaction. Some medications that operate on the same receptor (or tissue) differ in their ability to produce large biological reactions (i.e., their "efficacy") and the dosage needed to produce such responses (i.e., their "potency"). Drug receptors can be categorised according to how selectively they react to various medicines. Drugs can occasionally cause a diminished reaction when receptors or bodily systems are exposed to them repeatedly
Title : Hepatotoxic botanicals-shadows of pearls
Consolato M Sergi, Universities of Alberta and Ottawa, Canada
Title : Development of novel drug delivery pathways enabled by perillyl alcohol (NEO100), A monoterpene with multifaceted biomedical applications
Axel H Schonthal, University of Southern California, United States
Title : From marker to mechanism: Ligand discovery enables functional analysis of OR51E1, an ectopic olfactory receptor, in prostate cancer
Vladlen Slepak, University of Miami, United States
Title : The impact of metal-decorated polymeric nanodots on proton relaxivity
Paulo Cesar De Morais, Catholic University of Brasilia, Brazil
Title : Principles and standards for managing healthcare transformation towards personalized, preventive, predictive, participative precision medicine ecosystems
Bernd Blobel, University of Regensburg, Germany
Title : Personalized and Precision Medicine (PPM) as a unique healthcare model based on design-inspired biotech- & biopharma-driven applications to secure the human healthcare and biosafety
Sergey Suchkov, N D Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences & InMedStar, Russian Federation
Title : R&D consultancy at the medicines discovery catapult: De-risking drug discovery for innovators
Adriana Gambardella, Medicine Discovery Catapult, United Kingdom
Title : Biocompatible synthesis of non crystalline iron oxide nanoparticles with stable colloidal properties
Lan Wang, Paretor LLC, United States
Title : Hydrogen sulfide in sepsis: From bench to bedside
Madhav Bhatia, University of Otago, New Zealand
Title : Biocompatibility and subcutaneous host response to silk fibroin–chitosan composite plugs: Progress toward biodegradable implant materials
Luis Jesus Villarreal Gomez, Universidad Autónoma de Baja California, Mexico